Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-094383

Options or other derivatives

  • Chief Executive Officer acquired 130,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Weis Holger Chief Executive Officer 2025-07-02 Grant or award · Employee Stock Option (right to buy) +130,000 130,000 D
Loading xslF345X05/ownership.xml…